Fasiplon
From Infogalactic: the planetary knowledge core
Systematic (IUPAC) name | |
---|---|
6-Ethyl-7-methoxy-5-methyl-2-(5-methyl-[1,2,4]oxadiazol-3-yl)-imidazo[1,2-a]pyrimidine
|
|
Identifiers | |
CAS Number | 106100-65-6 |
ATC code | none |
PubChem | CID: 208954 |
ChemSpider | 181047 |
UNII | XCA050IPGB |
ChEMBL | CHEMBL62735 |
Chemical data | |
Formula | C13H15N5O2 |
Molecular mass | 273.290 g/mol |
|
|
|
|
(what is this?) (verify) |
Fasiplon (RU 33203) is a nonbenzodiazepine anxiolytic drug from the imidazopyrimidine family of drugs.
Fasiplon binds strongly to benzodiazepine sites on the GABAA receptor and has similar anxiolytic effects in animals, but with less sedative or muscle relaxant action.[1] It was developed by a team at Roussel Uclaf in the 1990s[2]
References
Categories:
- Chemical articles having calculated molecular weight overwritten
- Articles with changed InChI identifier
- Infobox drug articles without a structure image
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Sedatives
- Imidazopyrimidines
- Oxadiazoles
- GABAA receptor positive allosteric modulators